Wei-Qi Lu

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Zhi-Ming Wang, Rong-Yuan Zhuang, Xi Guo, Chen-Lu Zhang, Yang You, Li-Sha Chen, Wen-Shuai Liu, Yong Zhang, Rong-Kui Luo, Ying-Yong Hou, Wei-Qi Lu, Yu-Hong Zhou
Anlotinib plus epirubicin followed by anlotinib maintenance as first-line treatment for advanced soft tissue sarcoma: an open-label, single-arm, phase 2 trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)